-
Risk factors for recurrent implantation failure as defined by the European Society for Human Reproduction and Embryology Hum. Reprod. (IF 6.0) Pub Date : 2025-06-02
Can Wang, Youhui Lu, Miaoxian Ou, Lingxuan Qian, Yingying Zhang, Yuxin Yang, Lu Luo, Qiong WangSTUDY QUESTION What are the unrecognized risk factors for recurrent implantation failure (RIF) as defined in the ESHRE recommendation? SUMMARY ANSWER Anti-Müllerian hormone (AMH) is the strongest predictor for RIF, followed by chronic endometritis (CE), intrauterine adhesions, and BMI. WHAT IS KNOWN ALREADY Advanced age is a well-known risk factor for implantation failure, and the definition of RIF
-
Reply: Evaluation of methodological and analytical approaches in assessing intra-individual serum progesterone variability on frozen embryo transfer day across hormone replacement therapy cycles. Hum. Reprod. (IF 6.0) Pub Date : 2025-05-29
M Bourdon,C Maignien,C Patrat,J Guibourdenche,C Chapron,P Santulli -
Evaluation of methodological and analytical approaches in assessing intra-individual serum progesterone variability on frozen embryo transfer day across hormone replacement therapy cycles. Hum. Reprod. (IF 6.0) Pub Date : 2025-05-29
Onur Ince,Gonca Ozten Dere,Ali Can Gunes -
Association of insulin resistance with in vitro fertilization outcomes in women without polycystic ovarian syndrome: potential improvement with metformin treatment Hum. Reprod. (IF 6.0) Pub Date : 2025-05-29
Ana Belén Albert, Ana Corachán, Elena Juárez-Barber, Mauro Cozzolino, Antonio Pellicer, Diana Alecsandru, Irene Cervelló, Hortensia FerreroSTUDY QUESTION What is the association between insulin resistance (IR), metformin treatment, and the outcomes of IVF in IR infertile women without polycystic ovarian syndrome (non-PCOS)? SUMMARY ANSWER IR among non-PCOS infertile women was associated with worse IVF outcomes compared to insulin-sensitive (IS) infertile women, and metformin treatment prior to embryo transfer (ET) was associated with
-
Impact of definitive uterine artery occlusion on ovarian reserve markers in laparoscopic myomectomy: a randomized controlled trial with 2-year follow-up Hum. Reprod. (IF 6.0) Pub Date : 2025-05-27
I Streuli, L Ramyead, N Silvestrini, P Petignat, J DubuissonSTUDY QUESTION Does definitive occlusion of uterine arteries have a short- or long-term impact on ovarian reserve markers in reproductive-age women undergoing laparoscopic myomectomy? SUMMARY ANSWER Preventive definitive uterine artery occlusion (UAO) during laparoscopic myomectomy reduces intraoperative blood loss but does not impact serum AMH levels after short- and long-term follow-up in reproductive-age
-
Methods of family building used by sexual and gender minority adults in the United States Hum. Reprod. (IF 6.0) Pub Date : 2025-05-24
Diana M Tordoff, Stephanie A Leonard, Jiaqi Zhang, Ava Snow, Brent Monseur, Mahri A Bahati, Cassie Armea-Warren, Daniel Moretti, Micah E Lubensky, Annesa Flentje, Mitchell R Lunn, Juno Obedin-MaliverSTUDY QUESTION What methods are used by sexual and gender minority (SGM) parents to build their families? SUMMARY ANSWER SGM parents used diverse methods to build their families, which varied both by gender identity and age. WHAT IS KNOWN ALREADY Despite experiencing significant barriers to becoming parents, 63% of SGM adults aged 18–35 years old are considering having children or expanding their family
-
Novel insights into the lipid signalling in human spermatozoa Hum. Reprod. (IF 6.0) Pub Date : 2025-05-24
Steven Serafini, Cristian O’FlahertyInfertility, affecting one in six couples worldwide, poses significant health and social challenges. While both male and female factors contribute to infertility, male infertility causes remain underexplored, with about 34% of cases classified as unexplained. A few studies focus on the role of lipids in male fertility, and some lipids are rising as key players in spermatozoa. This review highlights
-
Detection of minimal residual disease in cryopreserved testicular tissue from (pre)pubertal boys with acute leukemia following first-line therapy Hum. Reprod. (IF 6.0) Pub Date : 2025-05-19
Aurélie Feraille, Pascaline Etancelin, Shirley Troche, Fabrice Jardin, Nimrod Buchbinder, Pascale Schneider, Magali Dugay, Nathalie Rives, Christine Rondanino, Ludovic DumontSTUDY QUESTION Is it feasible to detect minimal residual disease (MRD) in cryopreserved testicular tissue (TT) from (pre)pubertal boys diagnosed with acute leukemia using molecular biology techniques? SUMMARY ANSWER This pilot study demonstrates the feasibility of detecting MRD in cryopreserved TT, which could guide the choice of the safest techniques for fertility restoration. WHAT IS KNOWN ALREADY
-
Estradiol and progesterone levels in early pregnancy after modified natural, programmed, and gonadotrophin-stimulated frozen embryo transfer cycles: a randomized controlled trial Hum. Reprod. (IF 6.0) Pub Date : 2025-05-19
Nina Freiesleben Mørch, Hanne Udengaard, Marie Louise Borch, Michelle Saltoft Skovrup, Bugge Nøhr, Pernille Fog SvendsenSTUDY QUESTION Are serum estradiol and progesterone levels higher in women treated with programmed cycle (PC) FET compared to women treated with a gonadotrophin-stimulated (gSC) FET or a modified natural cycle (mNC) FET during early pregnancy? SUMMARY ANSWER Estradiol and progesterone levels are higher on the day of embryo transfer in women treated with PC compared to those treated with a mNC or gSC
-
Validity of administrative health data case definitions for identifying polycystic ovary syndrome: a systematic review and meta-analysis Hum. Reprod. (IF 6.0) Pub Date : 2025-05-18
Sophie Hu, Sophie Lalonde-Bester, Jenna Salem, Sheffinea Koshy, Donna Vine, Tyrone G Harrison, Jennifer M Yamamoto, Jamie L BenhamSTUDY QUESTION What is the validity of published administrative health data case definitions of polycystic ovary syndrome (PCOS) compared with reference standards? SUMMARY ANSWER Due to the limited number of eligible studies, drawing definitive conclusions is challenging; however, this review highlights significant gaps and variability in current PCOS case definitions, underscoring the need for standardized
-
Maternal polycystic ovarian syndrome and offspring psychopathology and neurodevelopment Hum. Reprod. (IF 6.0) Pub Date : 2025-05-17
Linda G Kahn, Alison E Hipwell, Mia Charifson, Rui Ling, Kim N Cajachagua-Torres, Akhgar GhassabianPolycystic ovarian syndrome (PCOS) is a common female endocrinologic condition that affects both the metabolic and reproductive systems and is the most frequent cause of anovulatory infertility. It is also associated with a range of psychiatric outcomes in individuals, including bulimia nervosa, schizophrenia, bipolar disorder, depression, anxiety, and personality disorders. At the same time, evidence
-
Normozoospermic infertile men possess subpopulations of sperm varying in DNA accessibility, relating to differing reproductive outcomes. Hum. Reprod. (IF 6.0) Pub Date : 2025-05-16
Mark E Gill,Manuel Fischer,Christian De Geyter,Antoine H F M PetersSTUDY QUESTION Can a reliable assay be developed to quantify DNA accessibility in human sperm to help with the assessment of pre-implantation development affected by dense packaging of mammalian sperm's genetic material? SUMMARY ANSWER We adapted NicE-view, an assay that directly labels accessible DNA, for use in human sperm and applied it to examine spermatozoa from infertile individuals with distinct
-
Reply: The role of light sheet microscopy for non-invasive imaging of live embryos. Hum. Reprod. (IF 6.0) Pub Date : 2025-05-15
F Horta,E Vargas-Ordaz,A Neild,V J Cadarso -
The role of light sheet microscopy for non-invasive imaging of live embryos. Hum. Reprod. (IF 6.0) Pub Date : 2025-05-15
Kylie R Dunning,Kishan Dholakia -
Analysis of maturation dynamics and oocyte nuclear quality after rescue-IVM and semi-automated vitrification. Hum. Reprod. (IF 6.0) Pub Date : 2025-05-15
L Chaput,S Dollet,E Eymard-Pierre,B Pereira,C Lucas,A-S Grémeau,A Tchirkov,G Marteil,F BrugnonSTUDY QUESTION What is the optimal stage (immature vs mature) and most efficient vitrification technique (semi-automated vs manual) to ensure the safety of the rescue-IVM (r-IVM) procedure for oocyte cryopreservation? SUMMARY ANSWER Human oocytes should be cryopreserved after r-IVM at the mature stage (r-MII oocytes) by semi-automated or manual vitrification. WHAT IS KNOWN ALREADY r-IVM of immature
-
SHR7280, an oral gonadotropin-releasing hormone antagonist, for the prevention of premature luteinizing hormone surge in controlled ovarian hyperstimulation: a dose-finding, phase 2 trial. Hum. Reprod. (IF 6.0) Pub Date : 2025-05-15
Hongbin Chi,Ying Song,Lei Jin,Xueru Song,Xiaohong Wang,Qianhong Ma,Yunxia Cao,Xiaoyan Liang,Jichun Tan,Yichun Guan,Feiyang Diao,Yanping Li,Zeli Li,Yuqi Sun,Chang Shu,Hong Chen,Kai Shen,Jie QiaoSTUDY QUESTION What is the minimum effective dose of SHR7280, a novel oral GnRH antagonist, to prevent a premature LH surge in women undergoing controlled ovarian hyperstimulation for ART? SUMMARY ANSWER SHR7280 at 200 mg once every 12 h (Q12h) was the minimal effective dose to suppress an LH surge and was associated with high-quality embryos, and a high clinical pregnancy rate. SHR7280 was well-tolerated
-
First-trimester maternal folate and vitamin B12 concentrations and their associations with first-trimester placental growth: the Rotterdam Periconception Cohort Hum. Reprod. (IF 6.0) Pub Date : 2025-05-15
M M van Vliet, S Schoenmakers, S P Willemsen, K D Sinclair, R P M Steegers-TheunissenSTUDY QUESTION Are maternal folate and vitamin B12 concentrations associated with first-trimester placental growth? SUMMARY ANSWER Maternal folate concentrations and commencement of folic acid supplements prior to conception, as compared to following conception, are positively associated with first-trimester placental volume (PV), whereas no associations were found for maternal vitamin B12 concentrations
-
Single-cell proteomics analysis of human oocytes during GV-to-MI transition Hum. Reprod. (IF 6.0) Pub Date : 2025-05-13
Zeling Zhang, Lei Luo, Shiwei Fan, Shun Bai, Bo XuSTUDY QUESTION Which proteins are involved in the transition of human oocytes from the germinal vesicle (GV) to metaphase I (MI) phase? SUMMARY ANSWER A total of 2369 proteins were identified, including 149 with significantly differential expression, 79 with upregulated expression in MI oocytes and 70 with downregulated expression. WHAT IS KNOWN ALREADY During oocyte maturation, maternal proteins and
-
The clinical impact of oligozoospermia in oocyte donation ICSI cycles using preimplantation genetic test for aneuploidy Hum. Reprod. (IF 6.0) Pub Date : 2025-05-13
Mauro Cozzolino, Livia Pellegrini, Christian Simon Ottolini, Antonio Capalbo, Daniela Galliano, Antonio PellicerSTUDY QUESTION Do severely impaired sperm concentrations (oligozoospemia) in male factor infertility affect embryo aneuploidy rates and clinical results after IVF oocyte donation cycles? SUMMARY ANSWER Severe oligozoospermia (SO) in IVF cycles utilizing donor oocytes does not significantly affect embryo euploidy rates or IVF outcomes or cumulative live birth rates (CLBRs). WHAT IS KNOWN ALREADY SO
-
Correction to: Pregnancy outcomes with increasing maternal age, greater than 40 years, in donor oocyte cycles. Hum. Reprod. (IF 6.0) Pub Date : 2025-05-12
-
Risk of endometriosis progression in infertile women trying to conceive naturally or using IVF. Hum. Reprod. (IF 6.0) Pub Date : 2025-05-09
Edgardo Somigliana,Paola Vigano',Dalila Invernici,Gianfranco Fornelli,Camilla Erminia Maria Merli,Paolo VercelliniThe use of hormonal treatments for endometriosis has increased in recent years. Their effectiveness lies in creating a stable hormonal environment, reducing peripheral estrogen levels, and suppressing ovulation and menstruation. Although these agents do not cure endometriosis and symptoms often return after discontinuation, they effectively relieve pain in most cases and help prevent disease progression
-
Preclinical validation of fast oocyte vitrification and warming protocols with comparable efficiencies to a standard method Hum. Reprod. (IF 6.0) Pub Date : 2025-05-07
Nuno Costa-Borges, Queralt Matia-Algué, Aila Coello, Enric Mestres, Mònica Acacio, Adolfo Flores-Saiffe Farias, Carolina Castello, Miguel Gallardo, Alejandro Chavez-Badiola, Francisco Marco-Jiménez, Ana Cobo, Jacques CohenSTUDY QUESTION Can fast vitrification (FV) and fast warming (FW) protocols effectively reduce oocyte exposure times to cryoprotectants while maintaining survival, developmental potential, and laboratory efficiency compared to a standard protocol? SUMMARY ANSWER FV and FW protocols significantly reduce exposure times compared to a standard protocol without compromising oocyte integrity or developmental
-
Dietary patterns and age at menarche in a prospective study of girls in the USA. Hum. Reprod. (IF 6.0) Pub Date : 2025-05-06
C P Davis,S Fest,K Cushing-Haugen,T W Kensler,J E Chavarro,H R HarrisSTUDY QUESTION Are dietary patterns associated with age at menarche after accounting for BMI-for-age (BMIz) and height? SUMMARY ANSWER We observed associations between both the Alternative Healthy Eating Index (AHEI) and the Empirical Dietary Inflammatory Pattern (EDIP) and age at menarche. WHAT IS KNOWN ALREADY Dietary patterns have been sparsely examined in relation to age at menarche and no studies
-
Oncostatin-M: a novel leukocyte-derived factor facilitating the ovulatory process in the human ovary Hum. Reprod. (IF 6.0) Pub Date : 2025-05-06
Yohan Choi, Mats Brännström, James W Akin, Ashley Teate, Lane K Christenson, Thomas E Curry, Misung JoSTUDY QUESTION Does leukocyte-derived Oncostatin-M (OSM) regulate the ovulatory process in human dominant follicles? SUMMARY ANSWER Leukocyte-derived OSM activates key signaling pathways in human preovulatory granulosa cells and modulates steroidogenesis, prostaglandin synthesis, and tissue remodeling in human ovulatory follicles. WHAT IS KNOWN ALREADY Leukocytes are essential regulators of ovulation
-
Association between endometriosis and type and age of menopause: a pooled analysis of 279 948 women from five cohort studies. Hum. Reprod. (IF 6.0) Pub Date : 2025-04-30
Hsin-Fang Chung,Kunihiko Hayashi,Annette J Dobson,Sven Sandin,Yuki Ideno,Rebecca Hardy,Elisabete Weiderpass,Gita D MishraSTUDY QUESTION What is the association between endometriosis and the type and age of menopause? SUMMARY ANSWER Women with endometriosis had a 7-fold increased risk of undergoing surgical menopause rather than natural menopause and were more likely to experience premature or early menopause, both surgically and naturally. WHAT IS KNOWN ALREADY Endometriosis is associated with reduced ovarian reserve
-
Hematologic cancers in women: from fertility preservation to post-cancer fertility outcomes. Hum. Reprod. (IF 6.0) Pub Date : 2025-04-30
E Goldenberg,C Sonigo,S Rakrouki,C Vinolas,F Eustache,V Puy,C Willekens,J Lazarovici,C Sifer,C Becquart,A Mayeur,A Benoit,M Grynberg,M PeignéSTUDY QUESTION How do hematological characteristics affect ovarian reserve, ovarian response to ovarian stimulation, and fertility outcomes? SUMMARY ANSWER Although lymphoma characteristics impact serum AMH levels, they do not affect, per se, the response to ovarian stimulation and the number of mature oocytes recovered at the time of fertility preservation; in addition, fertility in survivors of hematologic
-
Genomics in diagnosing primary ovarian insufficiency (POI): the door is open, but the path is still to be paved. Hum. Reprod. (IF 6.0) Pub Date : 2025-04-28
Omar F Ammar,George Liperis,Kashish Sharma,Zoya E Ali,Patricia Diaz-Gimeno,Filippo Zambelli,Martine A Gould,Vikram Talaulikar,Juan J Fraire-Zamora -
The Istanbul consensus update: a revised ESHRE/ALPHA consensus on oocyte and embryo static and dynamic morphological assessment†,‡. Hum. Reprod. (IF 6.0) Pub Date : 2025-04-28
,Giovanni Coticchio,Aisling Ahlström,Gemma Arroyo,Basak Balaban,Alison Campbell,Maria José De Los Santos,Thomas Ebner,David K Gardner,Borut Kovačič,Kersti Lundin,M Cristina Magli,Saria Mcheik,Dean E Morbeck,Laura Rienzi,Ioannis Sfontouris,Nathalie Vermeulen,Mina AlikaniSTUDY QUESTION What are the current recommended criteria for morphological assessment of oocytes, zygotes, and embryos? SUMMARY ANSWER The present ESHRE/Alpha Scientists in Reproductive Medicine consensus document provides several novel recommendations to assess oocyte and embryo morphology and rank embryos for transfer. WHAT IS KNOWN ALREADY A previous Alpha Scientists in Reproductive Medicine/ESHRE
-
Upregulation of immune genes in the proliferative phase endometrium enables classification into women with recurrent pregnancy loss versus controls Hum. Reprod. (IF 6.0) Pub Date : 2025-04-25
Laerke H J Andersen, Raquel Sanz Martinez, Yifan Dai, Jens Ole Eriksen, Maria K Gerlach, Lise Grupe Larsen, Nicholas S Macklon, Kristine Juul Hare, Albin Sandelin, Henriette Svarre Nielsen, Thomas Vauvert F HviidSTUDY QUESTION Does the transcriptome of preconceptional endometrium in the proliferative phase show a specific profile in women with recurrent pregnancy loss (RPL)? SUMMARY ANSWER A specific differential gene expression signature in endometrial samples for women experiencing RPL compared with IVF control women was identified including an RPL subgroup characterized by upregulation of immune-related
-
Thyroid function testing prior to fertility treatment: will we ever agree? Hum. Reprod. (IF 6.0) Pub Date : 2025-04-25
Sade Dunbar, Rima Dhillon-Smith, Abha MaheshwariThyroid disorders are among the most prevalent of medical conditions, especially in women, with the prevalence of both hypo- and hyper-thyroidism being 10-fold more common in women than in men. Thyroid hormones play a key role in subfertility associated with ovulatory dysfunction and miscarriages. While overt thyroid disorders are more often clinically diagnosed, subclinical hypothyroidism (SCH) poses
-
To be or not to be a sperm donor: global factors affecting sperm donation in the 21st century. Hum. Reprod. (IF 6.0) Pub Date : 2025-04-24
Mina Mincheva,Juan J Fraire-Zamora,Kashish Sharma,George Liperis,Omar F Ammar,Jackson Kirkman-Brown,Dorte L Egeberg,Mariana Veloso Martins,Lucy Frith,Julia Uraji -
Preconception sleep, pregnancy loss, and adverse pregnancy outcomes among women with a history of pregnancy loss Hum. Reprod. (IF 6.0) Pub Date : 2025-04-23
Joshua R Freeman, Brian W Whitcomb, Elizabeth R Bertone-Johnson, Louise M O’Brien, Galit L Dunietz, Alexandra C Purdue-Smithe, Keewan Kim, Robert M Silver, Enrique F Schisterman, Sunni L MumfordSTUDY QUESTION Are preconception sleep characteristics associated with pregnancy loss and adverse pregnancy outcomes? SUMMARY ANSWER Preconception sleep characteristics were not associated with pregnancy loss, but earlier sleep midpoints were associated with lower risk of adverse pregnancy outcomes, while social jetlag >1 h was associated with greater risk of a composite of adverse pregnancy outcomes
-
The phenotypic and genetic association between endometriosis and immunological diseases. Hum. Reprod. (IF 6.0) Pub Date : 2025-04-22
Nina Shigesi,Holly R Harris,Hai Fang,Anne Ndungu,Matthew R Lincoln,,,Chris Cotsapas,Julian Knight,Stacey A Missmer,Andrew P Morris,Christian M Becker,Nilufer Rahmioglu,Krina T ZondervanSTUDY QUESTION Is there an increased risk of immunological diseases among endometriosis patients, and does a shared genetic basis contribute to this risk? SUMMARY ANSWER Endometriosis patients show a significantly increased risk of autoimmune, autoinflammatory, and mixed-pattern diseases, including rheumatoid arthritis, multiple sclerosis, coeliac disease, osteoarthritis, and psoriasis, with genetic
-
An interpretable artificial intelligence approach to differentiate between blastocysts with similar or same morphological grades. Hum. Reprod. (IF 6.0) Pub Date : 2025-04-21
Hang Liu,Longbin Chen,Guanqiao Shan,Chen Sun,Changfu Lu,Hongqing Liao,Shuoping Zhang,Shaonan Dong,Xinxin Xu,Qiuyun Yan,Fei Gong,Zhuoran Zhang,Changsheng Dai,Wenyuan Chen,Haocong Song,Lei Chen,Shanshan Wang,Haixiang Sun,Ge Lin,Yu Sun,Yifan GuSTUDY QUESTION Can a quantitative method be developed to differentiate between blastocysts with similar or same inner cell mass (ICM) and trophectoderm (TE) grades, while also reflecting their potential for live birth? SUMMARY ANSWER We developed BlastScoringNet, an interpretable deep-learning model that quantifies blastocyst ICM and TE morphology with continuous scores, enabling finer differentiation
-
Prevalence of endometriosis in Mayer-Rokitansky-Küster-Hauser syndrome variants: a systematic review and meta-analysis. Hum. Reprod. (IF 6.0) Pub Date : 2025-04-17
Paolo Vercellini,Francesca Caprara,Martina Piccini,Agnese Donati,Paola Viganò,Edgardo Somigliana,Sonia CiprianiSTUDY QUESTION In patients with Mayer-Rokitansky-Küster-Hauser syndrome (MRKHS; population), is the presence of functional endometrium (FE) in uterine remnants (URs) (exposure), compared with the absence of FE in UR/absence of UR (comparison), associated with a higher prevalence of endometriosis (outcome)? SUMMARY ANSWER The aggregate prevalence of endometriosis was considerably higher in MRKHS patients
-
Reclassifying NOBOX variants in primary ovarian insufficiency cases with a corrected gene model and a novel quantitative framework Hum. Reprod. (IF 6.0) Pub Date : 2025-04-17
Reiner A Veitia, Jamie D Cowles, Sandrine CaburetSTUDY QUESTION How updated expression and genomic data combined with a disease/disorder-specific classification system can be used to correct a gene model for a better evaluation of the pathogenicity of variants found in patients? SUMMARY ANSWER By combining available genomic and transcriptomic data from several species and a quantitative classification framework with primary ovarian insufficiency
-
Racial and ethnic disparities in fecundability: a North American preconception cohort study Hum. Reprod. (IF 6.0) Pub Date : 2025-04-17
Lauren A Wise, Molly N Hoffman, Sharonda M Lovett, Ruth J Geller, Nina L Schrager, Ugochinyere Vivian Ukah, Amelia K Wesselink, Jasmine A Abrams, Renee Boynton-Jarrett, Wendy Kuohung, Andrea S Kuriyama, Matthew O Hunt, David R Williams, Collette N NcubeSTUDY QUESTION To what extent are there racial and ethnic disparities in fecundability in North America? SUMMARY ANSWER In a North American preconception cohort study, we observed large differences in fecundability across racial and ethnic groups. WHAT IS KNOWN ALREADY Several studies in the United States (USA) have shown that Black women tend to wait longer for fertility treatment and are less likely
-
International Committee for Monitoring Assisted Reproductive Technologies (ICMART): world report for cycles conducted in 2017–2018 Hum. Reprod. (IF 6.0) Pub Date : 2025-04-16
Valerie L Baker, Silke Dyer, Georgina M Chambers, Elena Keller, Manish Banker, Jacques de Mouzon, Eman Elgindy, Fu M Bai, Osamu Ishihara, Seung Chik Jwa, Markus S Kupka, Fernando Zegers-Hochschild, G David AdamsonSTUDY QUESTION What were the rates of utilization, effectiveness, and safety for assisted reproductive technology (ART) throughout the world in 2017 and 2018, and what trends were observed? SUMMARY ANSWER The total reported number of ART fresh and frozen cycles conducted in 83 participating countries was 2 913 498 in 2017 and 3 303 505 in 2018, with 5-year trends including an increasing proportion
-
A core outcome set for future male infertility research: development of an international consensus Hum. Reprod. (IF 6.0) Pub Date : 2025-04-16
Michael P Rimmer, Ruth A Howie, Richard A Anderson, Christopher L R Barratt, Kurt T Barnhart, Yusuf Beebeejaun, Ricardo Pimenta Bertolla, Pietro Bortoletto, Robert E Brannigan, Astrid E P Cantineau, Ettore Caroppo, Barbara L Collura, Kevin Coward, William Colin Duncan, Michael L Eisenberg, Steven A Gellatly, Christian De Geyter, Dimitrios G Goulis, Ralf R Henkel, Vu N A Ho, Alayman F Hussein, CarinSTUDY QUESTION Can a core outcome set be developed through a global consensus to standardize outcome selection, collection, comparison, and reporting in future male infertility trials? SUMMARY ANSWER A minimum dataset, known as a ‘core outcome set’, has been developed for randomized controlled trials (RCTs) and systematic reviews evaluating potential interventions for male infertility. WHAT IS KNOWN
-
COVID-19 vaccination and pregnancy-induced hypertension risk in women undergoing assisted reproduction. Hum. Reprod. (IF 6.0) Pub Date : 2025-04-11
Shujuan Ma,Yixiang Zheng,Mingli Fang,Yiquan Xiong,Liang Hu,Yvonne Liu,Fei Gong,Bernhard K Krämer,Ge Lin,Berthold HocherSTUDY QUESTION Does COVID-19 vaccination affect the risk of pregnancy-induced hypertension (PIH) in women undergoing ARTs, and does this risk differ based on vaccine type (inactivated vs recombinant) and timing relative to embryo transfer? SUMMARY ANSWER Women who received inactivated COVID-19 vaccines before undergoing ART had a significantly increased risk of developing PIH, particularly when vaccinated
-
Parents facing polygenic embryo scores: the ‘best choice of a best life’ and psychological counselling Hum. Reprod. (IF 6.0) Pub Date : 2025-04-10
Marina Forte, Daniela Galliano, Anna Maria Della Vedova, Antonio PellicerAdvances in reproductive medicine and genetic technologies now offer prospective parents the option to test IVF embryos for genetic predispositions to complex diseases, such as coronary heart disease and psychiatric disorders, through polygenic embryo screening (PES). However, limited clinical data on its real-world use leaves parents facing complex decisions based on probabilistic risk scores, requiring
-
'And Then There Were None'-the shrinkage of trials in the evidence ecosystem. Hum. Reprod. (IF 6.0) Pub Date : 2025-05-01
Rui Wang -
Growth hormone is not an ovulation induction agent. Hum. Reprod. (IF 6.0) Pub Date : 2025-05-01
Ulun Ulug -
Reply. Challenging the status quo: the future of growth hormone in IVF treatment. Hum. Reprod. (IF 6.0) Pub Date : 2025-05-01
Isaac-Jacques Kadoch -
Empirical use of growth hormone in IVF makes no sense. Hum. Reprod. (IF 6.0) Pub Date : 2025-05-01
Norbert Gleicher -
Randomized controlled trial to evaluate the impact of follicle priming on IVM outcomes in women with polycystic ovaries: CFA versus FSH-B Hum. Reprod. (IF 6.0) Pub Date : 2025-04-08
Michel De Vos, Linde Mostinckx, Panagiotis Drakopoulos, Ellen Anckaert, Johan Smitz, Shari Mackens, Christophe Blockeel, Ingrid SegersSTUDY QUESTION Do corifollitropin alfa (CFA) and follitropin beta (FSH-B) have different effects on oocyte yield and live birth rates (LBRs) after IVM in women with polycystic ovaries? SUMMARY ANSWER In patients who underwent IVM, one injection of CFA resulted in lower oocyte retrieval rates, but similar cumulative LBRs compared to three injections of FSH-B. WHAT IS KNOWN ALREADY IVM involves the maturation
-
Adoptive transfer of regulatory T cells inhibits the progression of endometriosis-like lesions in regulatory T-cell-depleted mice Hum. Reprod. (IF 6.0) Pub Date : 2025-04-04
Eiko Maeda, Hiroyuki Okimura, Yukiko Tanaka, Maya Fujii, Yosuke Tarumi, Hisashi Kataoka, Akemi Koshiba, Masahide Hamaguchi, Michiaki Fukui, Taisuke Mori, Jo KitawakiSTUDY QUESTION Does the restoration of regulatory T cells (Tregs) suppress the progression of endometriosis? SUMMARY ANSWER Adoptive transfer of Tregs suppresses the progression of endometriosis and reduces the levels of helper T (Th)-cell-related and proinflammatory cytokines in mice. WHAT IS KNOWN ALREADY Endometriosis is a chronic inflammatory gynecological disease, which involves multiple immune
-
'Ovariostasis' as the main preventive and therapeutic strategy for gynecological pathologies in women of reproductive age. Hum. Reprod. (IF 6.0) Pub Date : 2025-04-03
Antonio La Marca,Chiara SelmiOvariostasis is a reversible and temporary suspension of the cyclic ovarian activity, characterized by anovulation and hypogonadotropinemia (low serum concentrations of FSH and LH), which can be observed in case of pregnancy or hypothalamic amenorrhea or medically obtained through the administration of combined hormonal contraceptives, progestin-only pills, or GnRH analogues. Ovariostasis effectively
-
-
Profiling mitochondrial DNA variant segregation during human preimplantation development: a prerequisite to preimplantation genetic testing for mitochondrial DNA-related disorders. Hum. Reprod. (IF 6.0) Pub Date : 2025-05-01
Paula Rubens,Anne Mayeur,Kalliopi Chatzovoulou,Nadine Gigarel,Sophie Monnot,Agnès Rötig,Arnold Munnich,Nelly Frydman,Julie SteffannSTUDY QUESTION Is preimplantation genetic testing for mitochondrial DNA (mtDNA) disorders (PGT-mt) feasible at early compaction and blastocyst stages? SUMMARY ANSWER Pathogenic mtDNA variants segregate evenly among cell types and various lineages of a given embryo during preimplantation development, supporting the relevance of genetic analyses performed on Day 4 blastomere and on Day 5 or 6 trophectoderm
-
Reduced live birth rates following ART in adenomyosis patients: a matched control study Hum. Reprod. (IF 6.0) Pub Date : 2025-03-31
M Bourdon, A Mimouni, C Maignien, M Casalechi, P Vigano, C Bordonne, A E Millisher, C Patrat, L Marcellin, C Chapron, P SantulliSTUDY QUESTION How does adenomyosis affect live birth rates (LBRs) in women undergoing ART compared to a matched control population? SUMMARY ANSWER Women with adenomyosis, matched with controls for age, blastocyst count, and top-quality blastocyst count, exhibited reduced LBR following IVF/ICSI treatment. WHAT IS KNOWN ALREADY Adenomyosis, a benign uterine disorder, is believed to hinder implantation
-
Patients with endometriosis in the vagina, bowel, or bladder experience a prolonged diagnostic delay: an observational study Hum. Reprod. (IF 6.0) Pub Date : 2025-03-29
M E Madsen, D Hartwell, L K A Kähler, L Dyrved, B H Ejsing, L E Vexø, S E Thomassen, M C Havemann, A E Sakse, K Røssaak, M Nyegaard, H S NielsenSTUDY QUESTION Do the diagnostic delay and symptoms differ between endometriosis patients with advanced disease, defined as endometriosis involving the vagina, intestine, rectovaginal septum, or bladder (eVIRB), compared to patients without endometriosis in these locations (non-eVIRB)? SUMMARY ANSWER Patients with advanced endometriosis had a significantly longer diagnostic delay, an earlier onset
-
Risk of major gynecologic surgery before age 40 among daughters of young mothers. Hum. Reprod. (IF 6.0) Pub Date : 2025-05-01
Clarice R Weinberg,Olga Basso,Aimee A D'Aloisio,Dale P SandlerSTUDY QUESTION Is being born of a young mother associated with worse gynecologic health, as indicated by a bilateral oophorectomy or hysterectomy before age 40? SUMMARY ANSWER Daughters of mothers younger than 25 did not have reduced parity but did have a higher risk of having bilateral oophorectomy or hysterectomy before age 40, particularly if their mother was younger than 20 years at their birth
-
Swim-up versus density gradients for sperm preparation in infertile couples undergoing intrauterine insemination: a randomized clinical trial. Hum. Reprod. (IF 6.0) Pub Date : 2025-05-01
Tuyen N D Duong,Vinh Q Dang,Tien K Le,Anh T L Vu,Duy L Nguyen,Toan D Pham,Mai T Nguyen,Phuong T M Nguyen,Tuan M Vo,Chau T H Nguyen,Phuong T B Le,Anh H Le,Cam T Tran,Ben W Mol,Lan N Vuong,Tuong M HoSTUDY QUESTION What is the effectiveness of swim-up (SU) and density gradients (DG) for sperm preparation in infertile couples undergoing IUI? SUMMARY ANSWER In infertile couples undergoing IUI, SU and DG did not result in statistically significant different live birth rates. WHAT IS KNOWN ALREADY SU and DG are the two most commonly used techniques for sperm preparation in infertile couples undergoing
-
Optimizing Y-chromosome microdeletion screening in Chinese male infertility patients: a large-scale multi-centre study on incidence Hum. Reprod. (IF 6.0) Pub Date : 2025-03-23
Wei-Kang Chen, Zu-Bo Liu, Tong-Tong Lin, Yuan-Yuan Zhou, Le-Jun Li, Zhong-Yan Liang, Jing-Gen Wu, Fu Luo, Ke-Da Yu, Feng-Bin Zhang, Jing-Ping LiSTUDY QUESTION What is the optimal sperm concentration threshold for screening Y-chromosome microdeletions (YCMs) in male infertility patients? SUMMARY ANSWER This study identified three clinically relevant screening thresholds: an receiver operating characteristic (ROC)-optimal cutoff at 0.45 million sperm/ml, a high-sensitivity cutoff at 8 million sperm/ml, and a cost-effective threshold at 1 million
-
Bias due to non-consent in assisted reproductive treatment cohort studies: consent for disclosure to non-contact research in the Human Fertilisation and Embryology Authority register Hum. Reprod. (IF 6.0) Pub Date : 2025-03-23
Fiskani J M Kondowe, Matthew Gittins, Peter Clayton, Daniel R Brison, Stephen A RobertsSTUDY QUESTION Is patient consent to research associated with the distribution of population characteristics and study outcomes in ART cohort studies? SUMMARY ANSWER The distribution of population characteristics in the patient consent subset differs from that in the non-consent subset and is not fully representative of the general ART population; thus, study results of population subsets requiring
-
Pregnancy outcomes with increasing maternal age, greater than 40 years, in donor oocyte cycles Hum. Reprod. (IF 6.0) Pub Date : 2025-03-23
Sabbagh Riwa, Meyers Alison, Korkidakis Ann, Heyward Quetrell, Penzias Alan, Sakkas Denny, Vaughan Denis, Toth ThomasSTUDY QUESTION Do IVF outcomes differ in patients over the age of 40 using donor oocytes? SUMMARY ANSWER Even with the use of donor oocytes, maternal age appears to have an impact on live birth (LB) rate and perinatal outcomes. WHAT IS KNOWN ALREADY Maternal age has a significant impact on the outcome of IVF, mainly attributed to age-related oocyte chromosomal factors. STUDY DESIGN, SIZE, DURATION
-
Plasma metabolites associated with endometriosis in adolescents and young adults Hum. Reprod. (IF 6.0) Pub Date : 2025-03-19
Nan Lin, Oana A Zeleznik, Allison F Vitonis, Ashley Laliberte, Amy L Shafrir, Julian Avila-Pacheco, Clary Clish, Kathryn L Terry, Stacey A Missmer, Naoko SasamotoSTUDY QUESTION What are the plasma metabolomics profiles associated with endometriosis in adolescents and young adults? SUMMARY ANSWER Our findings show dysregulation of plasma metabolomic profiles in adolescents and young adults with endometriosis, revealing systemic elevation of fatty acyls and ceramides in endometriosis cases compared to controls. WHAT IS KNOWN ALREADY Endometriosis is a gynecologic
-
Clinical presentation of congenital hypogonadotropic hypogonadism in males with delayed puberty according to genetic etiology: a systematic review and meta-analysis after reclassification of gene variants Hum. Reprod. (IF 6.0) Pub Date : 2025-03-18
Sebastián Castro, Franco G Brunello, Gabriela Sansó, Agustín Izquierdo, Jonathan Zaiat, Mariela Urrutia, Marcelo Martí, Rodolfo A Rey, Mariana L Tellechea, Romina P GrinsponSTUDY QUESTION Which phenotypes can be confidently linked to a genetic etiology in males with congenital hypogonadotropic hypogonadism (CHH) resulting in absent or arrested puberty? SUMMARY ANSWER In this systematic review and reclassification of the disease-causing potential of gene variants using the recommendations of the American College of Medical Genetics and Genomics (ACMG) and the Association
-
Is it justified to offer intrauterine infusion of autologous PRP in women with repeated implantation failure? Hum. Reprod. (IF 6.0) Pub Date : 2025-05-01
Evangelia T Katsika,Christos A Venetis,Julia K Bosdou,Efstratios M KolibianakisIn recent years, an increased interest in the efficacy of intrauterine infusion of autologous platelet-rich plasma (PRP) in women with repeated implantation failure (RIF) has resulted in the publication of 13 randomized controlled trials (RCTs) and 11 meta-analyses. Although these meta-analyses support an increase in pregnancy rates after intrauterine infusion of autologous PRP, the low quality of